A Potent Bispecific Nanobody Protects hACE2 Mice Against SARS-CoV-2 Infection via Intranasal Administration
Copyright policy )A Potent Bispecific Nanobody Protects hACE2 Mice Against SARS-CoV-2 Infection via Intranasal Administration
AbstractThe dramatically expanding COVID-19 needs multiple effective countermeasures. Neutralizing antibodies are a potential therapeutic strategy for treating COVID-19. A number of neutralizing nanobodies (Nbs) were reported for their in vitro activities. However, in vivo protection of these nanobodies was not reported in animal models. In the current report, we characterized several RBD-specific Nbs isolated from a screen of an Nb library derived from an alpaca immunized with SARS-CoV-2 spike glycoprotein (S); among them, three Nbs exhibited picomolar potency against SARS-CoV-2 live virus, pseudotyped viruses, and 15 circulating SARS-CoV-2 variants. To improve the efficacy, various configurations of Nbs were engineered. Nb15-NbH-Nb15, a novel trimer constituted of three Nbs, was constructed to be bispecific for human serum albumin (HSA) and RBD of SARS-CoV-2. Nb15-NbH-Nb15 exhibited sub-ng/ml neutralization potency against the wild-type and currently circulating variants of SARS-CoV-2 with a long half-life in vivo. In addition, we showed that intranasal administration of Nb15-NbH-Nb15 provided 100% protection for both prophylactic and therapeutic purposes against SARS-CoV-2 infection in transgenic hACE2 mice. Nb15-NbH-Nb15 is a potential candidate for both prevention and treatment of SARS-CoV-2 through respiratory administration.One sentence summaryNb15-NbH-Nb15, with a novel heterotrimeric bispecific configuration, exhibited potent and broad neutralization potency against SARS-CoV-2 in vitro and provided in vivo protection against SARS-CoV-2 infection in hACE2 transgenic mice via intranasal delivery.Graphical abstract:HighlightsWe described a novel heterotrimeric configuration of Nb-NbH-Nb (Nb15-NbH-Nb15) that exhibited improved viral inhibition and stability.Nb15-NbH-Nb15 provides ultrahigh neutralization potency against SARS-CoV-2 wild type and 18 mutant variants, including the current circulating variants of D614G and N501Y predominantly in the UK and South Africa.It is the first to demonstrate the Nbs efficacy in preventing and treating SARS-CoV-2 infection in hACE2 transgenic mice via intranasal delivery.
- University of Chinese Academy of Sciences China (People's Republic of)
- Chinese Academy of Sciences China (People's Republic of)
- Nanjing University China (People's Republic of)
- Wuhan Institute of Virology China (People's Republic of)
- State Key Laboratory of Virology China (People's Republic of)
Male, QH301-705.5, hACE2 mice, Mice, Transgenic, bispecific, Antibodies, Viral, Article, Epitopes, Mice, Protein Domains, Neutralization Tests, Antibodies, Bispecific, Animals, Humans, Biology (General), Administration, Intranasal, SARS-CoV-2, intranasal, Antibodies, Monoclonal, COVID-19, Antibodies, Neutralizing, Mice, Inbred C57BL, nanobody, Kinetics, Nb15, Female, Angiotensin-Converting Enzyme 2, Camelids, New World, Protein Binding
Male, QH301-705.5, hACE2 mice, Mice, Transgenic, bispecific, Antibodies, Viral, Article, Epitopes, Mice, Protein Domains, Neutralization Tests, Antibodies, Bispecific, Animals, Humans, Biology (General), Administration, Intranasal, SARS-CoV-2, intranasal, Antibodies, Monoclonal, COVID-19, Antibodies, Neutralizing, Mice, Inbred C57BL, nanobody, Kinetics, Nb15, Female, Angiotensin-Converting Enzyme 2, Camelids, New World, Protein Binding
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).88 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 1% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 1%
Citations provided by BIP!Popularity provided by BIP!